Imedex Revenue and Competitors

Atlanta, GA USA

Location

N/A

Total Funding

Event Tech

Industry

Estimated Revenue & Valuation

  • Imedex's estimated annual revenue is currently $4.9M per year.(i)
  • Imedex's estimated revenue per employee is $112,000

Employee Data

  • Imedex has 44 Employees.(i)
  • Imedex grew their employee count by 2% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.8M7712%N/AN/A
#2
$3.5M33-34%$23.6MN/A
#3
$3.4M300%N/AN/A
#4
$4.9M442%N/AN/A
Add Company

Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality, scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management. Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 97,000 live meeting attendees since 2001, Imedex truly educates the global healthcare community. At Imedex, we believe that education is the best medicine. ®

keywords:N/A

N/A

Total Funding

44

Number of Employees

$4.9M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Imedex's People

NameTitleEmail/Phone
1
Accounting Operations ManagerReveal Email/Phone
2
Director, Educational ProgrammingReveal Email/Phone
3
Associate Art Director / Senior Graphic DesignerReveal Email/Phone
4
Accountant IIReveal Email/Phone
5
Director, Educational ProgrammingReveal Email/Phone
6
CEOReveal Email/Phone
7
Meeting PlannerReveal Email/Phone

Imedex News

2022-03-30 - Difficult-to-treat inflammatory bowel disease: results from a ...

... Cornerstones Health, and Imedex; and as a consultant or adviser to Boehringer Ingelheim, Gilead Sciences, Prometheus Biosciences, Takeda, UCB Biopharma,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.1M445%N/A
#2
$1.7M4410%N/A
#3
$3.5M44-2%N/A
#4
$9.5M44-2%N/A
#5
$5.6M4433%N/A